Biotricity Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2022	2021	2020	2019	2018	2017	2016	2016	2015	2014
Revenue	9.64	7.65	3.38	1.42	0.4	0	0	0	0	0
Revenue Growth (YoY)	26.00%	126.02%	138.75%	256.03%	-	-	-	-	-	-
Cost of Revenue	4.2	3.08	2.11	0.93	0.34	0	0	0	0	0
Gross Profit	5.44	4.57	1.27	0.49	0.06	0	0	0	0	0
Selling, General & Admin	17.62	18.56	12.57	10.05	7.34	5.96	4.8	3.88	3.99	0.87
Research & Development	3.23	2.74	2.06	1.36	1.31	1.76	1.14	1.09	1.14	0.83
Other Operating Expenses	0	0	0	0	0	0.88	1.18	0	0	0
Operating Expenses	20.85	21.31	14.62	11.42	8.65	8.6	7.12	4.97	5.13	1.71
Operating Income	-15.41	-16.74	-13.35	-10.93	-8.59	-8.6	-7.12	-4.97	-5.13	-1.71
Interest Expense / Income	1.84	1.28	0	0	0	0	0	0	0	0
Other Expense / Income	1.41	11.11	2.14	0.14	-	0.02	0.69	2.31	0.06	-
Pretax Income	-18.66	-29.13	-15.49	-11.07	-8.59	-8.62	-7.81	-7.28	-5.19	-1.71
Net Income	-18.66	-29.13	-15.49	-11.07	-8.59	-8.62	-7.81	-7.28	-5.19	-1.71
Preferred Dividends	0.88	1.09	0.96	0.26	0	0	0	0	0	0
Net Income Common	-19.53	-30.22	-16.45	-11.32	-8.59	-8.62	-7.81	-7.28	-5.19	-1.71
Shares Outstanding (Basic)	9	8	6	6	6	5	4	4	4	2
Shares Outstanding (Diluted)	9	8	6	6	6	5	4	4	4	2
Shares Change	14.32%	21.13%	4.36%	7.73%	10.64%	16.62%	0.21%	18.12%	51.66%	-
EPS (Basic)	-2.26	-3.99	-2.63	-1.89	-1.54	-1.72	-1.81	-1.74	-1.44	-0.72
EPS (Diluted)	-2.26	-3.99	-2.63	-1.89	-1.54	-1.72	-1.81	-1.74	-1.44	-0.72
Free Cash Flow	-13.55	-15.19	-11.08	-7.86	-5.22	-4.87	-3.75	-2.38	-1.96	-1.38
Free Cash Flow Per Share	-1.56	-2.01	-1.77	-1.31	-0.94	-0.97	-0.87	-0.55	-0.54	-0.57
Gross Margin	56.46%	59.74%	37.60%	34.26%	15.03%	-	-	-	-	-
Operating Margin	-159.87%	-218.77%	-394.47%	-771.00%	-2157.73%	-	-	-	-	-
Profit Margin	-202.65%	-395.01%	-486.10%	-798.81%	-2157.73%	-	-	-	-	-
Free Cash Flow Margin	-140.55%	-198.60%	-327.37%	-554.61%	-1311.11%	-	-	-	-	-
EBITDA	-16.47	-27.76	-15.49	-11.07	-8.59	-8.62	-7.81	-7.28	-5.19	-1.7
EBITDA Margin	-170.90%	-362.82%	-457.67%	-780.61%	-2157.73%	-	-	-	-	-
Depreciation & Amortization	0.35	0.09	0	0	0	0	0	0	0	0.01
EBIT	-16.82	-27.85	-15.49	-11.07	-8.59	-8.62	-7.81	-7.28	-5.19	-1.71
EBIT Margin	-174.49%	-364.00%	-457.67%	-780.61%	-2157.73%	-	-	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).